Early Weaning From Incubator To Crib
Launched by AUGUSTA UNIVERSITY · Jan 19, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether moving premature infants out of incubators and into cribs or bassinets earlier—specifically when they weigh around 1600 grams (about 3.5 pounds)—is safe and beneficial. The researchers believe that this early transition might help babies leave the hospital sooner while still growing at a healthy rate. They will closely monitor how long the babies stay in the hospital and how well they gain weight after being weaned from the incubator.
To participate in this study, infants need to have been born weighing less than 1600 grams. However, babies who have certain health conditions, like slow heart rates, need special light therapy, or require extra help breathing, are not eligible. If your baby meets the criteria, they will be part of a study that aims to improve care for newborns by exploring new ways to support their growth and recovery in a safe environment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Infants with a birth weight \<1600 gm
- Exclusion Criteria:
- • Infants who have bradycardia (HR\<80 bpm) that require stimulation for resolution.
- • Infants who require phototherapy.
- • Infants who require respiratory support \>2 liter per minute flow by nasal cannula, oxygen need can vary between 21-100%.
- • Infants with major congenital anomalies
About Augusta University
Augusta University is a prominent academic institution dedicated to advancing healthcare through innovative research and clinical trials. As a leader in medical education and patient care, Augusta University conducts rigorous clinical studies aimed at improving treatment outcomes and enhancing patient quality of life. The university’s commitment to interdisciplinary collaboration fosters a dynamic research environment, enabling the exploration of novel therapies and interventions across a wide range of medical fields. With a focus on ethical standards and patient safety, Augusta University strives to translate scientific discoveries into tangible benefits for the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Augusta, Georgia, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported